PHARMACIE SOLVAY

Herstal ·KBO/BCE: BE 0667.943.582

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	27-08-2025	27 d late	2025-00444230
31-12-2023	31-07-2024	10-07-2024	21 d early	2024-00240095
31-12-2022	31-07-2023	28-08-2023	28 d late	2023-00405432
31-12-2021	31-07-2022	14-07-2022	17 d early	2022-20195937
31-12-2020	31-07-2021	31-08-2021	31 d late	2021-62200119
31-12-2019	31-07-2020	31-08-2020	31 d late	2020-50200229
31-12-2018	31-07-2019	22-08-2019	22 d late	2019-51000258
31-12-2017	31-07-2018	31-07-2018	on the day	2018-41000163

Metric	This company	Sector median	Position in the sector
Solvency	-21.7%	17.2%	better than 11% of 873 sector peers
Net result	€-32k	€14k	better than 20% of 874 sector peers
Equity	€-120k	€99k	better than 10% of 875 sector peers
Gross operating margin	€415k	€213k	better than 69% of 801 sector peers
Staff costs	€424k	€221k	higher than 70% of 721 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€555k
Fixed assets	21/28	€120k
Tangible fixed assets	22/27	€109k
Financial fixed assets	28	€11k
Current assets	29/58	€435k
Stocks & contracts in progress	3	€226k
Amounts receivable within one year	40/41	€204k
Cash & bank	54/58	€4k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€555k
Equity	10/15	€-120k
Contributions / capital	10/11	€19k
Accumulated profits (losses)	14	€-139k
Amounts payable	17/49	€675k
Amounts payable within one year	42/48	€675k
Trade debts payable within one year	44	€119k
Income statement
Gross operating margin	9900	€415k
Operating result	9901	€-33k
Financial income	75	€3k
Financial charges	65	€2k
Result before taxes	9903	€-32k
Net result for the period	9904	€-32k
Result to be appropriated	9905	€-32k

Summary